<GlossaryTerm id="CDR0000512981"><TermName>forodesine hydrochloride</TermName><TermPronunciation>(FOR-oh-deh-seen HY-droh-KLOR-ide)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called BCX-1777.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718402" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;forodesine hydrochloride&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718403" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de forodesina&quot;" language="es" id="_4"/><SpanishTermName>clorhidrato de forodesina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de leucemia y linfoma. Es un tipo de inhibidor de la enzima purina-nucleósido fosforilasa (PNP). También se llama BCX-1777.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2007-06-19</DateLastModified></GlossaryTerm>
